Academic Journal
Subsequent Anti-Myeloma Therapy after Idecabtagene Vicleucel (ide-cel, bb2121) Treatment in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) from the KarMMa Study
| العنوان: | Subsequent Anti-Myeloma Therapy after Idecabtagene Vicleucel (ide-cel, bb2121) Treatment in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) from the KarMMa Study |
|---|---|
| المؤلفون: | Munshi, Nikhil C., San-Miguel, Jesús, Anderson Jr., Larry D., Lonial, Sagar, Truppel-Hartmann, Anna, Sanford, Jill, Rowe, Everton, Campbell, Timothy B., Rodriguez-Otero, Paula |
| المصدر: | Transplantation and Cellular Therapy ; volume 28, issue 3, page S171 ; ISSN 2666-6367 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s2666-6367(22)00372-4 |
| الاتاحة: | http://dx.doi.org/10.1016/s2666-6367(22)00372-4 https://api.elsevier.com/content/article/PII:S2666636722003724?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S2666636722003724?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: | edsbas.5EA48DC4 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s2666-6367(22)00372-4 |
|---|